Rare diseases
Investigational molecules
Locations
459 conditions with trials, the busiest first
1 397 trials across Europe, recruiting first
A Phase 3 Randomized Study of Rozanolixizumab for Safety and Efficacy in Adults with Ocular Myasthenia Gravis
FranceA study to test if BHV-8000 is effective and safe for adults with early Parkinson's disease
AustriaStudy of Lactobacillales and Lacidofil in Multiple Sclerosis Patients: Comparing Effectiveness of Probiotic Therapy
PolandStudy on the Effectiveness and Safety of BHV-7000 for Adults with Refractory Focal Onset Epilepsy
AustriaOne-Year Open-Label Extension Study Evaluating Safety and Efficacy of Huperzine A as Adjunctive Therapy in Adults with Focal Onset Seizures
HungaryEfficacy and Safety of OXT-328 5% Topical Gel for Symptom Relief in Patients with Chemotherapy‑Induced, Diabetic, and Cervical Radiculopathy Peripheral Neuropathy
GreeceSafety and Early Benefit of Allogeneic Bone Marrow‑Derived Mesenchymal Stromal Cells in Children and Adolescents with X‑Linked Adrenoleukodystrophy
SpainPhase 3 Study of Pridopidine Hydrochloride for Safety and Efficacy in Adults with Huntington’s Disease
BelgiumLong‑term safety study of alpelisib alone or with fulvestrant in adults with breast cancer who benefited from previous alpelisib treatment
BulgariaEfficacy of upadacitinib plus short prednisolone tapering in adults with Giant Cell Arteritis
GermanyStudy of Lidocaine Gel (drug combination) vs Standard Gel for Pain Relief in Patients Undergoing Double-J Ureteral Stent Placement or Exchange
GermanyLong‑term study of Pompe disease in all patients receiving alglucosidase alfa drug combination (miglustat, cipaglucosidase alfa, avalglucosidase alfa)
The NetherlandsThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
